Trader consensus on Polymarket reflects an 83% implied probability for no new WHO-designated COVID variant of concern before 2027, driven by the recent emergence of SARS-CoV-2 BA.3.2—nicknamed "Cicada"—which has spread to dozens of U.S. states and European countries since late 2025 but remains classified only as a variant under monitoring. Despite its mutations enabling some immune escape, health agencies like WHO and CDC report no evidence of heightened severity, hospitalizations, or vaccine failure, with Cicada comprising under 1% of sequences. Widespread hybrid immunity from boosters and prior infections, coupled with robust global surveillance, has tempered fears, though a sudden surge in transmissibility or lethality could prompt reclassification and shift odds.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日はい
$231,738 Vol.
$231,738 Vol.
はい
$231,738 Vol.
$231,738 Vol.
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
マーケット開始日： Dec 1, 2025, 4:49 PM ET
Resolver
0x65070BE91...The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Resolver
0x65070BE91...Trader consensus on Polymarket reflects an 83% implied probability for no new WHO-designated COVID variant of concern before 2027, driven by the recent emergence of SARS-CoV-2 BA.3.2—nicknamed "Cicada"—which has spread to dozens of U.S. states and European countries since late 2025 but remains classified only as a variant under monitoring. Despite its mutations enabling some immune escape, health agencies like WHO and CDC report no evidence of heightened severity, hospitalizations, or vaccine failure, with Cicada comprising under 1% of sequences. Widespread hybrid immunity from boosters and prior infections, coupled with robust global surveillance, has tempered fears, though a sudden surge in transmissibility or lethality could prompt reclassification and shift odds.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日
外部リンクに注意してください。
外部リンクに注意してください。
よくある質問